Pharmaceutical News

RSS

FDA-approved anti-seizure drug could help fight Alzheimer's disease

While physicians and scientists have long known Alzheimer's disease involves the buildup of toxic protein fragments in the brain, they have struggled to understand how these harmful fragments are produced.

12 Feb 2026

Adjunctive brexpiprazole boosts schizophrenia patients' information processing speed

Cognitive impairment, including decreased attention and memory, remains one of the most disabling aspects of schizophrenia, affecting social life of patients.

12 Feb 2026

Weight loss drug tirzepatide may lower the risk of diabetic retinopathy

The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators.

11 Feb 2026

Semaglutide lowers cardiovascular events even without major weight loss, researchers report

Semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease regardless of baseline adiposity. Cardiovascular benefit was largely independent of overall weight loss, with waist circumference reduction explaining only part of the effect.

11 Feb 2026

Study suggests shingles vaccine may help lower Alzheimer’s and dementia risk

A large observational electronic health record study found that older adults receiving the recombinant zoster vaccine showed substantially lower rates of diagnosed dementia compared with matched unvaccinated individuals. The association persisted after multiple sensitivity analyses, although causality remains unproven and longer follow-up is required given the long latency of dementia.

10 Feb 2026

Three PBMs dominate retail prescriptions in Medicare Part D and Medicaid markets

Just three pharmacy benefit managers (PBM) dominate retail prescriptions in Medicare Part D and Medicaid managed care across much of the country, with markets in in nearly every state considered highly concentrated for at least one program, according to a new study from the USC Schaeffer Center for Health Policy & Economics.

10 Feb 2026

US cancer institute studying ivermectin’s ‘ability to kill cancer cells’

The National Cancer Institute, the federal research agency charged with leading the war against the nation's second-largest killer, is studying ivermectin as a potential cancer treatment, according to its top official.

10 Feb 2026

Long-term omeprazole use linked to mineral imbalance risks

A study conducted in Brazil by researchers at the Federal University of São Paulo (UNIFESP) and the ABC Medical School (FMABC) warns that the prolonged use of proton pump inhibitors (PPIs) can impair nutrient absorption.

9 Feb 2026

Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation

Tirzepatide significantly improved cardiometabolic risk markers in adults with obesity and moderate to severe obstructive sleep apnea in the SURMOUNT-OSA phase 3 trials. Mediation analyses suggest both weight loss and reduced sleep-disordered breathing contributed to improvements in inflammation, insulin resistance, lipids, and blood pressure.

9 Feb 2026

Most statin side effects are not backed by trials

Research indicates that many statin therapy side effects are not supported by evidence, suggesting a need for revised labeling to improve treatment decisions.

9 Feb 2026

Large Swedish study finds COVID-19 vaccination unrelated to fertility or childbirth rates

A Swedish registry-based cohort study evaluated whether COVID-19 vaccination affected childbirth rates among women aged 18 to 45 years during the pandemic period. No statistically significant association was found between vaccination, childbirth, or recorded miscarriage rates, suggesting demographic and socioeconomic factors likely explain observed fertility trends.

8 Feb 2026

Sustainable pharmacy initiatives needed to reduce environmental harm from medicines

The group of the EHU - University of the Basque Country is proposing various initiatives designed to reduce the presence of medicines in the environment and, consequently, their effects on human health.

6 Feb 2026

Climate change is accelerating antibiotic resistance across the Western Pacific

Urgent action is needed as climate change fuels antibiotic resistance in the Western Pacific, threatening health and highlighting socioeconomic vulnerabilities.

6 Feb 2026

Large trials show statins rarely cause reported side effects

Cardiovascular disease results in around 20 million deaths worldwide and causes around a quarter of all deaths in the UK.

5 Feb 2026

Trazodone linked to safer delirium outcomes in older adults

A large U.S. study suggests that older adults hospitalized with delirium may experience better outcomes when treated with trazodone, commonly used to treat depression and sleep problems, rather than commonly used antipsychotic medications.

3 Feb 2026

Everday diabetes medicine linked to less progression of age-related macular degeneration

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries.

3 Feb 2026

How the CDC prepares influenza vaccines for pandemics

CDC scientists outline the comprehensive methodology involved in the development of influenza candidate vaccine viruses.

2 Feb 2026

African investment vital for medical research and innovation

Africa’s health future hinges on its ability to finance and commercialise its own medical innovations, rather than rely on increasingly uncertain international funding, African science leaders have warned.

31 Jan 2026

Solvent-free method improves drug solubility using mesoporous silica

A large share of medicines developed today may never reach patients for a surprisingly simple reason: they cannot dissolve well enough in water.

31 Jan 2026

Algae4IBD conference highlights seaweed-driven health innovations

Leading academics from universities and research organizations across Europe and America, and companies and SMEs interested in developing foods, supplements and pharmaceuticals targeting pain and inflammation will gather for the Algae4IBD Conference and Industry Summit, taking place at the Conference Center, Teagasc Food Research Center, Ashtown, Dublin 15 from March 4th-6th, 2026.

31 Jan 2026

Pharmaceutical News

FDA-approved anti-seizure drug could help fight Alzheimer's disease

Adjunctive brexpiprazole boosts schizophrenia patients' information processing speed

Weight loss drug tirzepatide may lower the risk of diabetic retinopathy

Semaglutide lowers cardiovascular events even without major weight loss, researchers report

Study suggests shingles vaccine may help lower Alzheimer’s and dementia risk

Three PBMs dominate retail prescriptions in Medicare Part D and Medicaid markets

US cancer institute studying ivermectin’s ‘ability to kill cancer cells’

Long-term omeprazole use linked to mineral imbalance risks

Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation

Most statin side effects are not backed by trials

Large Swedish study finds COVID-19 vaccination unrelated to fertility or childbirth rates

Sustainable pharmacy initiatives needed to reduce environmental harm from medicines

Climate change is accelerating antibiotic resistance across the Western Pacific

Large trials show statins rarely cause reported side effects

Trazodone linked to safer delirium outcomes in older adults

Everday diabetes medicine linked to less progression of age-related macular degeneration

How the CDC prepares influenza vaccines for pandemics

African investment vital for medical research and innovation

Solvent-free method improves drug solubility using mesoporous silica

Algae4IBD conference highlights seaweed-driven health innovations

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News